acyclovir
Generic: acyclovir
Labeler: proficient rx lpDrug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
proficient rx lp
Dosage Form
TABLET
Routes
Active Ingredients
acyclovir 800 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
82804-012
Product ID
82804-012_14b524cc-8610-480d-8ce1-ab11f2a9f4d0
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA210401
Listing Expiration
2026-12-31
Marketing Start
2023-06-20
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
82804012
Hyphenated Format
82804-012
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA210401 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 800 mg/1
Packaging
- 30 TABLET in 1 BOTTLE (82804-012-30)
- 35 TABLET in 1 BOTTLE (82804-012-35)
- 50 TABLET in 1 BOTTLE (82804-012-50)
- 60 TABLET in 1 BOTTLE (82804-012-60)
- 90 TABLET in 1 BOTTLE (82804-012-90)
Packages (5)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "14b524cc-8610-480d-8ce1-ab11f2a9f4d0", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0382804012305"], "unii": ["X4HES1O11F"], "rxcui": ["197313"], "spl_set_id": ["d0908b3c-f5dd-4113-9080-bb01abe13c9c"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Proficient Rx LP"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (82804-012-30)", "package_ndc": "82804-012-30", "marketing_start_date": "20230921"}, {"sample": false, "description": "35 TABLET in 1 BOTTLE (82804-012-35)", "package_ndc": "82804-012-35", "marketing_start_date": "20231116"}, {"sample": false, "description": "50 TABLET in 1 BOTTLE (82804-012-50)", "package_ndc": "82804-012-50", "marketing_start_date": "20250709"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (82804-012-60)", "package_ndc": "82804-012-60", "marketing_start_date": "20230921"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (82804-012-90)", "package_ndc": "82804-012-90", "marketing_start_date": "20230921"}], "brand_name": "Acyclovir", "product_id": "82804-012_14b524cc-8610-480d-8ce1-ab11f2a9f4d0", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "82804-012", "generic_name": "Acyclovir", "labeler_name": "Proficient Rx LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "800 mg/1"}], "application_number": "ANDA210401", "marketing_category": "ANDA", "marketing_start_date": "20230620", "listing_expiration_date": "20261231"}